{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:08:42Z","timestamp":1780524522872,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s10067-017-3880-6","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T04:39:12Z","timestamp":1508992752000},"page":"757-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status"],"prefix":"10.1007","volume":"37","author":[{"given":"Tamer A","family":"Gheita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gada S","family":"Azkalany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7754-5581","authenticated-orcid":false,"given":"Nevin","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AH","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"issue":"4","key":"3880_CR1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","volume":"134","author":"A Farina","year":"2014","unstructured":"Farina A, Cirone M, York M, Lenna S, Padilla C, Mclaughlin S et al (2014) Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J Investig Dermatol 134(4):954\u2013964","journal-title":"J Investig Dermatol"},{"issue":"11","key":"3880_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.autrev.2015.07.006","volume":"14","author":"E Gianchecchi","year":"2015","unstructured":"Gianchecchi E, Fierabracci A (2015) Gene\/environment interactions in the pathogenesis of autoimmunity: new insights on the role of toll-like receptors. Autoimmun Rev 14(11):971\u2013983","journal-title":"Autoimmun Rev"},{"issue":"23","key":"3880_CR3","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/j.febslet.2011.04.028","volume":"585","author":"KCM Santegoets","year":"2011","unstructured":"Santegoets KCM, van Bon L, van den Berg WB, Wenink MH, Radstake TRDJ (2011) Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs? FEBS Lett 585(23):3660\u20133666","journal-title":"FEBS Lett"},{"issue":"5","key":"3880_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10409238.2015.1033511","volume":"50","author":"CE Bryant","year":"2015","unstructured":"Bryant CE, Gay NJ, Heymans S, Sacre S, Schaefer L, Midwood KS (2015) Advances in toll-like receptor biology: modes of activation by diverse stimuli. Crit Rev Biochem Mol Biol 50(5):359\u2013379","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"57","key":"3880_CR5","doi-asserted-by":"crossref","first-page":"57ra82","DOI":"10.1126\/scitranslmed.3001510","volume":"2","author":"G Trujillo","year":"2010","unstructured":"Trujillo G, Meneghin A, Flaherty KR, Sholl LM, Myers JL, Kazerooni EA et al (2010) TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med 2(57):57ra82","journal-title":"Sci Transl Med"},{"issue":"2","key":"3880_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","volume":"47","author":"Y Liu","year":"2014","unstructured":"Liu Y, Yin H, Zhao M, Lu Q (2014) TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 47(2):136\u2013147","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"3880_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","volume":"67","author":"T Takahashi","year":"2015","unstructured":"Takahashi T, Asano Y, Ichimura Y, Toyama T, Taniguchi T, Noda S et al (2015) Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Arthritis Rheumatol 67(1):254\u2013265","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"3880_CR8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","volume":"172","author":"A Yoshizaki","year":"2008","unstructured":"Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E et al (2008) CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 172(6):1650\u20131663","journal-title":"Am J Pathol"},{"issue":"3","key":"3880_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/icb.2008.101","volume":"87","author":"A Chockalingam","year":"2009","unstructured":"Chockalingam A, Brooks JC, Cameron JL, Blum LK, Leifer CA (2009) TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol Cell Biol 87(3):209\u2013217","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"3880_CR10","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/art.39655","volume":"68","author":"F Fang","year":"2016","unstructured":"Fang F, Marangoni RG, Zhou X, Yang Y, Ye B, Shangguang A et al (2016) Toll-like receptor 9 signaling is augmented in systemic sclerosis and elicits transforming growth factor beta-dependent fibroblast activation. Arthritis Rheumatol 68(8):1989\u20132002","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3880_CR11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","volume":"68","author":"A Mavropoulos","year":"2016","unstructured":"Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari CG, Bogdanos DP et al (2016) Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol 68(2):494\u2013504","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"3880_CR12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2009.128207","volume":"69","author":"L Bon van","year":"2010","unstructured":"van Bon L, Popa C, Huijbens R, Vonk M, York M, Simms R et al (2010) Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 69(8):1539\u20131547","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3880_CR13","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen","year":"2013","unstructured":"Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheumatol 65(11):2737\u20132747","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3880_CR14","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJ et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"issue":"7","key":"3880_CR15","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281\u20131285","journal-title":"J Rheumatol"},{"issue":"3 Suppl 29","key":"3880_CR16","first-page":"S42","volume":"21","author":"TAJ Medsger","year":"2003","unstructured":"Medsger TAJ, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(3 Suppl 29):S42\u2013S46","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"3880_CR17","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","volume":"40","author":"VD Steen","year":"1997","unstructured":"Steen VD, Medsger TAJ (1997) The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40(11):1984\u20131991","journal-title":"Arthritis Rheum"},{"key":"3880_CR18","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly S (2017) Toll like receptors in systemic sclerosis: an emerging target. Immunol Lett. \nhttps:\/\/doi.org\/10.1016\/j.imlet.2017.09.001","DOI":"10.1016\/j.imlet.2017.09.001"},{"key":"3880_CR19","doi-asserted-by":"crossref","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP et al (2015) Systemic sclerosis. Nat Rev 1:15002","DOI":"10.1038\/nrdp.2015.2"},{"issue":"2","key":"3880_CR20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240\u2013273 Table of Contents","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"3880_CR21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","volume":"17","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya S, Varga J (2015) Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep 17(1):474","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"3880_CR22","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1136\/annrheumdis-2015-207405","volume":"75","author":"A Yoshizaki","year":"2016","unstructured":"Yoshizaki A, Taniguchi T, Saigusa R, Fukasawa T, Ebata S, Numajiri H et al (2016) Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells. Ann Rheum Dis 75(10):1858\u20131865","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3880_CR23","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kew251","volume":"55","author":"L Bon van","year":"2016","unstructured":"van Bon L, Cossu M, Scharstuhl A, Pennings BWC, Vonk MC, Vreman HJ et al (2016) Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered toll-like receptor response: another role for CXCL4? Rheumatology (Oxford) 55(11):2066\u20132073","journal-title":"Rheumatology (Oxford)"},{"key":"3880_CR24","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2013.10","volume":"15","author":"M Ciechomska","year":"2013","unstructured":"Ciechomska M, Cant R, Finnigan J, van Laar JM, O\u2019Reilly S (2013) Role of toll-like receptors in systemic sclerosis. Expert Rev Mol Med 15:e9","journal-title":"Expert Rev Mol Med"},{"key":"3880_CR25","doi-asserted-by":"publisher","unstructured":"Song IJ, Yang YM, Inokuchi-Shimizu S, Roh YS, Yang L, Seki E (2017) The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice. Int J Cancer. \nhttps:\/\/doi.org\/10.1002\/ijc.31029","DOI":"10.1002\/ijc.31029"},{"issue":"5","key":"3880_CR26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.21867","volume":"46","author":"A Watanabe","year":"2007","unstructured":"Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA et al (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46(5):1509\u20131518","journal-title":"Hepatology"},{"key":"3880_CR27","doi-asserted-by":"crossref","unstructured":"Sacre SM, Drexler SK, Foxwell BM (2005) Toll-like receptors and rheumatoid arthritis: is there a connection?. In: O\u2019Neill LAJ, Brint E (eds) Toll-like Receptors in Inflammation. Birkhauser, Basel, p 19\u201340","DOI":"10.1007\/3-7643-7441-1_2"},{"issue":"5","key":"3880_CR28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3899\/jrheum.100732","volume":"38","author":"Y Tamaki","year":"2011","unstructured":"Tamaki Y, Takakubo Y, Hirayama T, Konttinen YT, Goodman SB, Yamakawa M et al (2011) Expression of toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol 38(5):810\u2013820","journal-title":"J Rheumatol"},{"issue":"10","key":"3880_CR29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00296-010-1472-8","volume":"31","author":"EO Etem","year":"2011","unstructured":"Etem EO, Elyas H, Ozgocmen S, Yildirim A, Godekmerdan A (2011) The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int 31(10):1369\u20131374","journal-title":"Rheumatol Int"},{"key":"3880_CR30","doi-asserted-by":"crossref","unstructured":"Lacerte P, Brunet A, Egarnes B, Duch\u00eane B, Brown JP, Gosselin J (2016) Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists. Arthritis Res Ther 18(1):10","DOI":"10.1186\/s13075-015-0901-1"},{"issue":"4","key":"3880_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/187152807783334300","volume":"6","author":"S Sun","year":"2007","unstructured":"Sun S, Rao NL, Venable J, Thurmond R, Karlsson L (2007) TLR7\/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allergy Drug Targets 6(4):223\u2013235","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"5","key":"3880_CR32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","volume":"37","author":"N Fullard","year":"2015","unstructured":"Fullard N, O\u2019Reilly S (2015) Role of innate immune system in systemic sclerosis. Semin Immunopathol 37(5):511\u2013517","journal-title":"Semin Immunopathol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3880-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3880-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3880-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T23:25:28Z","timestamp":1520033128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3880-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3880"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3880-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}